Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Braz J Microbiol ; 50(2): 347-355, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30877662

RESUMO

Recombinant virus vectors represent a promising strategy for vaccine research. Among available viral vectors, members of the Poxviridae family-especially the modified Vaccinia virus Ankara (MVA)-stand out as immunogenic and safe vaccine platforms. Because MVA usually does not produce plaques in cell culture, visible selection markers such as the green fluorescent protein (GFP) are frequently incorporated into the constructions in order to facilitate the recognition of recombinants. However, these genetic markers have to be removed before any clinical trial. Here, we evaluated the acute responses generated in mice immunized with a MVA vector in which the GFP marker was not removed. We observed no differences in neutrophil, monocyte, or total leucocyte recruitment among animals inoculated with MVA or MVA-GFP. Likewise, there were no differences in neutrophil activation between mice groups. Hepatic functions were not altered in either MVA or MVA-GFP-inoculated mice, and we observed no histopathological alterations in different tissues from virus-inoculated animals. In conclusion, the presence of GFP is innocuous to immunized animals and do not alter acute physiopathological responses to the MVA vector. We suggest that keeping the GFP marker may be a good strategy for vaccine development, production, and evaluation.


Assuntos
Proteínas de Fluorescência Verde/efeitos adversos , Vacinas Atenuadas/imunologia , Vaccinia virus/genética , Vaccinia virus/imunologia , Vacinas Virais/imunologia , Animais , Feminino , Proteínas de Fluorescência Verde/genética , Camundongos , Camundongos Endogâmicos BALB C , Monócitos/imunologia , Neutrófilos/imunologia , Varíola/prevenção & controle , Vacinação , Vacinas de DNA
2.
J Biomed Mater Res B Appl Biomater ; 105(4): 715-722, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-26699416

RESUMO

ISO 10993-5 provides one of the accepted standards for testing the biotoxicity of new materials. All of the recommended test procedures rely upon the uptake or metabolism of dye by living cells. Results of direct contact tests can be potentially compromised by interaction or adsorption of the dye or its metabolic products. Therefore, the aim of the current study was to validate the use of the eGFP signal of transfected NIH-3T3 fibroblasts with the results of the MTT test in order to provide a test procedure that is very close to the ISO 10993-5 but has the advantage of not relying on the addition of dye. Our tests show that the MTT assay detects cytotoxicity in the eGFP NIH-3T3 cells at least as well as in the L929 cells. To facilitate the validation, we chose to integrate the fluorescence measurements into the MTT test procedure. To that end, an additional washing step was introduced. Additionally, medium without phenol red was used, resulting in a very high correlation of both measurements. Without these modifications, the fluorescence test was comparable to the MTT test in its ability to detect the cytotoxic potential of substances; however, it did result in slightly elevated IC50 concentrations. As the results of both tests correlated highly, measurement of the eGFP signal appears to present a reliable tool for detecting cytotoxicity of materials in line with the ISO 10993-5 norm with the advantage of avoiding the addition of dyes and the subsequent potential interaction with test materials. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 715-722, 2017.


Assuntos
Fluorescência , Proteínas de Fluorescência Verde/biossíntese , Teste de Materiais , Transfecção , Animais , Sobrevivência Celular/genética , Proteínas de Fluorescência Verde/efeitos adversos , Proteínas de Fluorescência Verde/genética , Camundongos , Células NIH 3T3
3.
Stem Cell Rev Rep ; 12(5): 553-559, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27435468

RESUMO

Green Fluorescent protein (GFP), used as a cellular tag, provides researchers with a valuable method of measuring gene expression and cell tracking. However, there is evidence to suggest that the immunogenicity and cytotoxicity of GFP potentially confounds the interpretation of in vivo experimental data. Studies have shown that GFP expression can deteriorate over time as GFP tagged cells are prone to death. Therefore, the cells that were originally marked with GFP do not survive and cannot be accurately traced over time. This review will present current evidence for the immunogenicity and cytotoxicity of GFP in in vivo studies by characterizing these responses.


Assuntos
Rastreamento de Células/efeitos adversos , Proteínas de Fluorescência Verde/efeitos adversos , Proteínas de Fluorescência Verde/imunologia , Animais , Expressão Gênica/genética , Proteínas Luminescentes/efeitos adversos , Proteínas Luminescentes/imunologia
4.
Acta Biochim Pol ; 61(4): 809-13, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25379570

RESUMO

The use of fluorescent markers has proven to be an attractive tool in biological imaging. However, its usefulness may be confined by the cytotoxicity of the fluorescent proteins. In this article, for the first time, we have examined an influence of the antibiotics present in culture medium on cytotoxicity of the EGFP and DsRed2 markers used for whole-cell labeling. Results showed that doxycycline negatively affected albumin synthesis in DsRed2-expressing hepatoma cells, and that both hepatoma cells and human skin fibroblasts, labeled with this protein, were characterized by the lowered growth rates. Thus, the cytotoxic effect of fluorescent markers depends on both protein used for cell labeling and on growth conditions that may cause cell stress.


Assuntos
Antibacterianos/farmacologia , Proteínas de Fluorescência Verde/efeitos adversos , Proteínas Luminescentes/efeitos adversos , Linhagem Celular , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Humanos
5.
Transgenic Res ; 21(4): 773-84, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22173943

RESUMO

Since large animal transgenesis has been successfully attempted for the first time about 25 years ago, the technology has been applied in various lines of transgenic pigs. Nevertheless one of the concerns with the technology--animal welfare--has not been approached through systematic assessment and statements regarding the welfare of transgenic pigs have been based on anecdotal observations during early stages of transgenic programs. The main aim of the present study was therefore to perform an extensive welfare assessment comparing heterozygous transgenic animals expressing GFP with wildtype animals along various stages of post natal development. The protocol used covered reproductory performance and behaviour in GFP and wildtype sows and general health and development, social behaviour, exploratory behaviour and emotionality in GFP and wildtype littermates from birth until an age of roughly 4 months. The absence of significant differences between GFP and wildtype animals in the parameters observed suggests that the transgenic animals in question are unlikely to suffer from deleterious effects of transgene expression on their welfare and thus support existing anecdotal observations of pigs expressing GFP as healthy. Although the results are not surprising in the light of previous experience, they give a more solid fundament to the evaluation of GFP expression as being relatively non-invasive in pigs. The present study may furthermore serve as starting point for researchers aiming at a systematic characterization of welfare relevant effects in the line of transgenic pigs they are working with.


Assuntos
Bem-Estar do Animal , Animais Geneticamente Modificados/crescimento & desenvolvimento , Técnicas de Transferência de Genes/efeitos adversos , Proteínas de Fluorescência Verde/efeitos adversos , Animais , Expressão Gênica , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Sus scrofa/crescimento & desenvolvimento
6.
Bull Cancer ; 93(11): 1131-8, 2006 Nov.
Artigo em Francês | MEDLINE | ID: mdl-17145583

RESUMO

The forming of secondary tumors, called metastases, constitutes the first cause of death of the patients reached by a cancer and represents one of the major obstacles in the fight against this disease. The characterization of mechanisms governing the passage of the cancerous phenotype into metastasis thus turns out to be a crucial stage for the discovery of new treatments. The understanding, and finally the inhibition of a so complex and multifactorial process, require the implementation of various strategies of study (e.g. inhibition of the neo-angiogenesis, impact of the expression or of the inhibition of a gene, test of a new molecule, etc.). However, whatever is the envisaged type of work, the use of in vivo models remains always essential. Unfortunately, although the classic approaches to show and count the metastases (histology, immunohistochemistry, etc.) allowed the better understanding of the metastatic process, these techniques dramatically underestimate the real number of metastases in a given tissue, because they do not allow the detection of the micrometastases. The aim of this article is to present a new approach in the models of studies of the metastases, using cancerous cells stably expressing the green fluorescent protein (GFP). The fluorescence emitted by the GFP, induced by UV radiation, allows to show up to the unicellular level the cancerous cells present to the healthy tissue of the host and so to estimate in a relative precise way their number. In addition, the power of detection of these models can be combined to video devices, allowing to follow the evolution of the tumor growth and the metastatic spread during time, and it on the same animal. These new models radically change the classic approaches of study of metastatic spread and open the way new types of works till now impracticable. In addition, besides the aptness of these models, we will also discuss their weaknesses, and will present some recent examples of applications.


Assuntos
Fluorescência , Proteínas de Fluorescência Verde/metabolismo , Metástase Neoplásica/diagnóstico , Animais , Proteínas de Fluorescência Verde/efeitos adversos , Proteínas de Fluorescência Verde/efeitos da radiação , Humanos , Camundongos , Camundongos Transgênicos , Metástase Neoplásica/prevenção & controle , Metástase Neoplásica/terapia , Espécies Reativas de Oxigênio/metabolismo , Raios Ultravioleta
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA